Terms: = Prostate cancer AND NCKIPSD, AF3P21, 51517, ENSG00000213672, SPIN90, WASLBP, Q9NZQ3, WISH, ORF1 AND Diagnosis
35 results:
1. Do all prostate cancer patients want, and experience shared decision making prior to curative treatment?
Otrebski Nilsson M; Aas K; Myklebust TÅ; Gjelsvik YM; Haug ES; Fosså SD; Johannesen TB
Scand J Urol; 2023 Dec; 58():133-140. PubMed ID: 38116675
[TBL] [Abstract] [Full Text] [Related]
2. Genome Reporting for Healthy Populations-Pipeline for Genomic Screening from the GENCOV COVID-19 Study.
Frangione E; Chung M; Casalino S; MacDonald G; Chowdhary S; Mighton C; Faghfoury H; Bombard Y; Strug L; Pugh T; Simpson J; Hao L; Lebo M; Lane WJ; Taher J; Lerner-Ellis J;
Curr Protoc; 2022 Oct; 2(10):e534. PubMed ID: 36205462
[TBL] [Abstract] [Full Text] [Related]
3. Diagnostic potential of radiological apical tumor involvement.
Liebert C; Morka N; Satish P; Freeman A; Kelly D; Kirkham A; Orczyk C; Simpson BS; Whitaker HC; Emberton M; Norris JM
J Robot Surg; 2023 Apr; 17(2):705-706. PubMed ID: 35414034
[TBL] [Abstract] [Full Text] [Related]
4. Psychosocial Barriers and Enablers for prostate cancer Patients in Starting a Relationship.
Mathew S; Rapsey CM; Wibowo E
J Sex Marital Ther; 2020; 46(8):736-746. PubMed ID: 32835628
[TBL] [Abstract] [Full Text] [Related]
5. Not all prostate cancer is the same - patient perceptions: an Asia-Pacific region study.
Akakura K; Bolton D; Grillo V; Mermod N
BJU Int; 2020 Sep; 126 Suppl 1():38-45. PubMed ID: 32521568
[TBL] [Abstract] [Full Text] [Related]
6. Radiomics Driven Diffusion Weighted Imaging Sensing Strategies for Zone-Level prostate cancer Sensing.
Dulhanty C; Wang L; Cheng M; Gunraj H; Khalvati F; Haider MA; Wong A
Sensors (Basel); 2020 Mar; 20(5):. PubMed ID: 32164378
[TBL] [Abstract] [Full Text] [Related]
7. Determinants for choosing and adhering to active surveillance for localised prostate cancer: a nationwide population-based study.
Bergengren O; Garmo H; Bratt O; Holmberg L; Johansson E; Bill-Axelson A
BMJ Open; 2019 Dec; 9(12):e033944. PubMed ID: 31874896
[TBL] [Abstract] [Full Text] [Related]
8. [Supportive Care and Information Needs of cancer Survivors: A Comparison of Two Cohorts of Longterm cancers Survivors 5 and 10 Years after Primary cancer diagnosis].
Lehmann-Laue A; Ernst J; Mehnert A; Taubenheim S; Lordick F; Götze H
Psychother Psychosom Med Psychol; 2020 Apr; 70(3-04):130-137. PubMed ID: 31466113
[TBL] [Abstract] [Full Text] [Related]
9. [The option of non-treatment as part of end-of-life care].
Hendriksen G; van Delden JJM
Ned Tijdschr Geneeskd; 2019 May; 163():. PubMed ID: 31187971
[TBL] [Abstract] [Full Text] [Related]
10. [A paradigm shift for prostate cancer diagnostics].
Bratt O
Lakartidningen; 2018 Oct; 115():. PubMed ID: 30351441
[TBL] [Abstract] [Full Text] [Related]
11. A mitochondrial based oncology platform for targeting cancer stem cells (CSCs): MITO-ONC-RX.
Sotgia F; Ozsvari B; Fiorillo M; De Francesco EM; Bonuccelli G; Lisanti MP
Cell Cycle; 2018; 17(17):2091-2100. PubMed ID: 30257595
[TBL] [Abstract] [Full Text] [Related]
12. Influence of lifestyle and genetic variants in the aldo-keto reductase 1C3 rs12529 polymorphism in high-risk prostate cancer detection variability assessed between US and New Zealand cohorts.
Karunasinghe N; Ambs S; Wang A; Tang W; Zhu S; Dorsey TH; Goudie M; Masters JG; Ferguson LR
PLoS One; 2018; 13(6):e0199122. PubMed ID: 29920533
[TBL] [Abstract] [Full Text] [Related]
13. Communicating risk in active surveillance of localised prostate cancer: a protocol for a qualitative study.
Rapport F; Hogden A; Gurney H; Gillatt D; Bierbaum M; Shih P; Churruca K
BMJ Open; 2017 Oct; 7(10):e017372. PubMed ID: 28982830
[TBL] [Abstract] [Full Text] [Related]
14. Practice Patterns in the diagnosis and Management of Hypogonadism: A Survey of Sexual Medicine Society of North America Members.
Yafi FA; Haney NM; Anaissie J; DeLay KJ; Trost L; Khera M; Hellstrom WJG
Urology; 2017 Aug; 106():87-95. PubMed ID: 28479477
[TBL] [Abstract] [Full Text] [Related]
15. Effectiveness of community-based football compared to usual care in men with prostate cancer: Protocol for a randomised, controlled, parallel group, multicenter superiority trial (The FC prostate Community Trial).
Bjerre E; Bruun DM; Tolver A; Brasso K; Krustrup P; Johansen C; Christensen R; Rørth M; Midtgaard J
BMC Cancer; 2016 Oct; 16(1):767. PubMed ID: 27716218
[TBL] [Abstract] [Full Text] [Related]
16. A cohort analysis of men with a family history of BRCA1/2 and Lynch mutations for prostate cancer.
Kerr L; Rewhorn MJ; Longmuir M; Fraser S; Walsh S; Andrew N; Leung HY
BMC Cancer; 2016 Jul; 16():529. PubMed ID: 27456091
[TBL] [Abstract] [Full Text] [Related]
17. Surveillance of the adult cancer survivor.
Wilbur J
Am Fam Physician; 2015 Jan; 91(1):29-36. PubMed ID: 25591198
[TBL] [Abstract] [Full Text] [Related]
18. Urologists' personal feelings on PSA screening and prostate cancer treatment.
Wenzler DL; Rosenberg BH
J Eval Clin Pract; 2014 Aug; 20(4):408-10. PubMed ID: 24798149
[TBL] [Abstract] [Full Text] [Related]
19. What should we tell prostate cancer patients about (secondary) prevention?
Chan JM; Van Blarigan EL; Kenfield SA
Curr Opin Urol; 2014 May; 24(3):318-23. PubMed ID: 24625429
[TBL] [Abstract] [Full Text] [Related]
20. [prostate cancer: how do patients choose their treatment?].
Enel C; Matte A; Berchi C; Binquet C; Cormier L; Lejeune C
Bull Cancer; 2013 Mar; 100(3):191-9. PubMed ID: 23500637
[TBL] [Abstract] [Full Text] [Related]
[Next]
